The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions
Abstract
1,5-anhydroglucitol (1,5-AG) is a validated marker of short-term glycemic control. It is a metabolically inert polyol that competes with glucose for reabsorption in the kidneys. Otherwise stable levels of 1,5-AG are rapidly depleted as blood glucose levels exceed the renal threshold for glucosuria. 1,5-AG more accurately predicts rapid changes in glycemia than hemoglobin A1C (A1C) or fructosamine. It is also more tightly associated with glucose fluctuations and postprandial glucose. Thus, 1,5-AG may offer complementary information to A1C. This review will summarize the limitations of current methods of assessing glycemic control, assess the data to support 1,5-AG as a glycemic marker and highlight the scenarios by which 1,5-AG may fill the gap in assessing glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Khaw, K.-T., Wareham, N., Bingham, S., Luben, R., Welch, A., & Day, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00006 · Cited by 974
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666
Deiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
Cited by
Individual variability in human blood metabolites identifies age-related differences
Chaleckis, R., Murakami, I., Takada, J., Kondoh, H., & Yanagida, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603023113 · Cited by 373
“4A), known as a glycemic marker (76), showed”
BackgroundPitfalls in Hemoglobin A1c Measurement: When Results may be Misleading
Radin, M. S. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2595-x · Cited by 361
Gender-specific pathway differences in the human serum metabolome
Krumsiek, J., Mittelstrass, K., Do, K. T., Stückler, F., Ried, J., Adamski, J., Peters, A., Illig, T., Kronenberg, F., Friedrich, N., et al. (2015) · Metabolomics · doi:10.1007/s11306-015-0829-0 · Cited by 291
de Bock, M., Codner, E., Craig, M. E., Huynh, T., Maahs, D. M., Mahmud, F. H., Marcovecchio, L., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13455 · Cited by 254
Lorenzo-Almorós, A., Hang, T., Peiró, C., Soriano-Guillén, L., Egido, J., Tuñón, J., & Lorenzo, Ó. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0935-9 · Cited by 202
Parrinello, C. M., & Selvin, E. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0548-3 · Cited by 154
Update on biomarkers of glycemic control
Krhač, M., & Lovrenčić, M. V. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i1.1 · Cited by 93
Corcoran, S. M., Achamallah, N., Loughlin, J. O., Stafford, P., Dicker, P., Malone, F. D., & Breathnach, F. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.12.051 · Cited by 40
Racial differences in and prognostic value of biomarkers of hyperglycemia
Parrinello, C. M., Sharrett, A. R., Maruthur, N. M., Bergenstal, R. M., Grams, M. E., Coresh, J., & Selvin, E. (2016) · Diabetes Care · doi:10.2337/dc15-1360 · Cited by 29
Loomis, S. J., Köttgen, A., Li, M., Tin, A., Coresh, J., Boerwinkle, E., Gibbs, R., Muzny, D., Pankow, J., Selvin, E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42202-0 · Cited by 12
Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0849 · Cited by 7
Metadata
- Authors
- Dungan, K. M.
- Venue
- Expert Review of Molecular Diagnostics
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 9-19
- ISSN
- 1473-7159 (ISSN-L)
- 1744-8352
- OpenAlex
- W2108260538
- Cited by
- 207
- References
- 16
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.